Keyword: Lipitor

Markets & Companies

Injecting Growth and Innovation

13.09.2019 - Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...

News

Pfizer Abandons $118 billion AstraZeneca Takeover

27.05.2014 - In a move widely expected, Pfizer abandoned its attempt to buy AstraZeneca for nearly £70 billion ($118 billion) on May 26 as a final deadline mandated by British law approached...

News

Pharmaceutical industry and the VUCA challenges

14.02.2014 - Increasing price pressures on established pharmaceutical markets are requiring extensive adjustments to pharmaceutical business models and the growth rates of most emerging market...

Plant Construction & Process Technology

Camelot’s Pharma Management Radar

24.10.2013 - End Of Patent Protection - The global pharmaceutical industry is steering toward the patent cliff: Some of the biggest blockbuster drugs in history - Lipitor, Plavix and Viagra -...

Plant Construction & Process Technology

Thriving Generics

25.09.2012 - Market Transition - When we think about the patent cliff, an image along the lines of a massive waterfall, with companies' revenues in free fall comes to mind. What we usually...

News

Pfizer Beats Forecasts, Helped by Cost Cuts

31.07.2012 - Pfizer reported higher-than-expected quarterly earnings, helped by cuts in research spending and other costs, and affirmed its 2012 profit forecast despite the negative impact of...

News

Pfizer Sued by Retailers for Generic Lipitor Delay

06.07.2012 - Five big U.S. retailers filed an antitrust lawsuit against Pfizer and India's Ranbaxy Laboratories on Thursday, accusing them of conspiring to delay sales of generic versions of...

News

Peter Pollak on the World of Fine Chemicals

26.10.2011 - In his book "Fine Chemicals - The Industry and the Business," Dr. Peter Pollak provides a comprehensive view on one of the most challenging segments of the modern chemical industry...